OHSU in the news

TKI discontinuation safe in CML, improved PROs

MedPage Today November 12, 2020
Brian Druker, M.D., and Ted Braun, M.D., Ph.D., co-author an invited commentary in JAMA Oncology on the “consequential” patient-reported outcomes found in a clinical trial studying chronic myeloid leukemia patients who remained in treatment-free remission after tyrosine kinase inhibition treatment discontinuation. “These findings provide objective evidence that important measures of quality of life do improve off therapy.”

Polysubstance use common in SUD patients

Psychiatric News November 12, 2020
Psychiatric News interviews Honora Englander, M.D., about a recent study finding that more than half of patients hospitalized with a substance use disorder use more than one substance: “The recent national focus on the ‘opioid epidemic,’ while important, may miss the mark and oversimplify patterns of substance use for many people.”

There are advantages to in-person COVID testing, health experts say

KATU-TV November 12, 2020
In a story about in-home tests, Donna Hansel, M.D., Ph.D., says it’s still critical to talk with your doctor: “The disease varies a lot from person to person, symptoms vary a lot, rate of progression varies person to person, and I think having a conduit to ask those questions and receive that information is very important.”

Prostate Cancer Foundation, Dana-Farber Cancer Institute and Oregon Health & Science University partner to advance prostate cancer treatment for our nation’s veterans

Prostate Cancer Foundation November 11, 2020
A press release announces the VA Portland Health Care System and OHSU will receive $2.5 million in funding to launch a center of excellence dedicated to prostate cancer. Julie Graff, M.D., says: “This award will make it possible for us to reach out to veterans throughout Oregon and Southwest Washington to offer genetic testing and sequencing for all patients with metastatic prostate cancer.”

After a vaccine, public acceptance is the next challenge, PSU expert says

Portland Business Journal November 11, 2020
David Bangsberg, M.D., and Carlos Crespo, Dr.PH., speak with the Portland Business Journalabout public health impacts of COVID-19 and public acceptance of a potential vaccine. Bangsberg says: “There are two big ifs: scaling it [COVID-19 vaccine] up and encouraging the public to trust the vaccine.”

Cannabis to treat gynecological conditions

Journal of Women's Health November 10, 2020
Research led by Leo Han, M.D., and colleagues suggests an increase in patient acceptance of utilizing cannabis to treat gynecological conditions.
See more stories